Formic Acid

Formic Acid

SCHEMBL30439433

COc1ncc(F)c2c(S(=O)(=O)N3CCCNC[C@H]3C)cccc12.O=CO

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 11/20 0.61
▸ ROCK1 Q13464 11/20 0.61
▸ PRKCD Q05655 4/20 0.61
▸ PLK4 O00444 2/20 0.61
▸ MARK3 P27448 2/20 0.61
▸ PRKAA1 Q13131 2/20 0.61
▸ PKN2 Q16513 2/20 0.61
▸ MARK2 Q7KZI7 2/20 0.61
▸ AURKB Q96GD4 2/20 0.61
▸ PRKD2 Q9BZL6 2/20 0.61
▸ NQO2 P16083 1/20 0.61
▸ MAP2K3 P46734 1/20 0.61
▸ CDK9 P50750 1/20 0.61
▸ PRKAG1 P54619 1/20 0.61
▸ PKN1 Q16512 1/20 0.61
▸ MAP4K3 Q8IVH8 1/20 0.61
▸ TAOK3 Q9H2K8 1/20 0.61
▸ PRKACA P17612 4/20 0.53
▸ PRKD3 O94806 3/20 0.53
▸ PRKCZ Q05513 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL23795352 1.00 ROCK2 (0.61) ROCK2ROCK1PRKCDPLK4MARK3
Formic Acid SCHEMBL30439342 1.00 ROCK2 (0.61) ROCK2ROCK1PRKCDPLK4MARK3
Formic Acid SCHEMBL23795351 1.00 ROCK2 (0.61) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL30438688 0.96 ROCK2 (0.66) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL23795310 0.96 ROCK2 (0.66) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL30439357 0.96 ROCK2 (0.66) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL23795309 0.96 ROCK2 (0.66) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL23795405 0.85 ROCK2 (0.59) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL23795342 0.85 ROCK2 (0.59) ROCK2ROCK1PRKCDPLK4MARK3
SCHEMBL23795409 0.85 ROCK2 (0.68) ROCK2ROCK1PRKCDPLK4MARK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback